Third dose of the BNT162b2 vaccine results in very high levels of neutralizing antibodies against SARS-CoV-2: Results of a prospective study in 150 health professionals in Greece.
Am J Hematol
; 97(4): E147-E150, 2022 04.
Article
in English
| MEDLINE | ID: covidwho-1620096
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
COVID-19
/
BNT162 Vaccine
Type of study:
Cohort study
/
Observational study
/
Prognostic study
Topics:
Vaccines
Limits:
Humans
Country/Region as subject:
Europa
Language:
English
Journal:
Am J Hematol
Year:
2022
Document Type:
Article
Affiliation country:
Ajh.26468
Similar
MEDLINE
...
LILACS
LIS